Real-world evidence for steroidal mineralocorticoid receptor antagonists in patients with chronic kidney disease

BACKGROUND: Mineralocorticoid receptor antagonists (MRAs) were shown to delay chronic kidney disease (CKD) progression in patients with hypertension and/or heart failure (HF) and proteinuria. OBJECTIVE: We conducted a systematic literature review on real-world evidence to identify the literature gap...

Descripción completa

Detalles Bibliográficos
Autores principales: Folkerts, Kerstin, Millier, Aurelie, Smela, Beata, Olewinska, Elzbieta, Schmedt, Niklas, Mernagh, Paul, Kovesdy, Csaba P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Systematic Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10227157/
https://www.ncbi.nlm.nih.gov/pubmed/36422853
http://dx.doi.org/10.1007/s40620-022-01492-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10227157/
https://www.ncbi.nlm.nih.gov/pubmed/36422853
http://dx.doi.org/10.1007/s40620-022-01492-w

Ejemplares similares